Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Takeda, Affymax in Omontys Supply Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Takeda, Affymax in Omontys Supply Pact

Will work with DSI Renal to integrate Omontys into their dialysis centers

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Takeda Pharmaceuticals America, Inc. (TPA) and Affymax, Inc. have entered into a supply agreement for sourcing and supply of Omontys (peginesatide) Injection with DSI Renal, one of the largest dialysis providers in the U.S. Omontys is the only once-monthly erythropoiesis-stimulating agent (ESA) for anemia in adult dialysis patients with chronic kidney disease (CKD) in the U.S.
 
The agreement allows DSI Renal to purchase Omontys for use within its organization and provides for discounts and rebates on the product, subject to certain requirements. DSI Renal plans to initially evaluate Omontys in selected centers, and will then evaluate the potential to expand to additional centers. Financial terms were not disclosed.
 
“We look forward to working with DSI Renal as they integrate Omontys into their dialysis centers,” said John Orwin, chief executive officer of Affymax. “With this agreement, we now have supply agreements in place with five out of the six medium-sized dialysis organizations in the U.S.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters